[Alcohol withdrawal and its major complications]

Area of Science:

• Neurology
• Addiction Medicine
• Internal Medicine

Background:

• Delirium tremens is a critical complication of alcohol withdrawal syndrome.
• Early detection and intensive management are crucial due to its potentially lethal nature.

Purpose of the Study:

• To provide an overview of alcohol withdrawal, including risk assessment, differential diagnoses, and treatment options.
• To highlight the utility of the Luebeck Alcohol-Withdrawal Risk Scale short form (LARS-11) in predicting severe withdrawal.
• To emphasize prompt management of potential co-occurring conditions like Wernicke-Encephalopathy.

Main Methods:

• Review of current guidelines and literature on alcohol withdrawal and delirium tremens.
• Discussion of risk assessment tools, specifically the LARS-11.
• Outline of recommended pharmacological and supportive treatments.

Main Results:

• The LARS-11 can adequately predict the risk of severe alcohol withdrawal.
• Parenteral Vitamin B1 and oral Magnesium are recommended for severe withdrawal symptoms due to potential Wernicke-Encephalopathy overlap.
• Benzodiazepines are the primary treatment for delirium tremens, often supplemented with Haloperidol for hallucinations.

Conclusions:

• Effective management of alcohol withdrawal and delirium tremens relies on early risk assessment and timely, intensive treatment.
• Integrated treatment approaches addressing potential co-existing conditions are essential for favorable outcomes.
• Adherence to established guidelines ensures optimal patient care for this serious condition.